(RTTNews) - Disc Medicine, Inc. (IRON), a clinical-stage biopharmaceutical company, announced on Tuesday that it has received positive feedback from the U.S. Food and Drug Administration or FDA ...

More importantly from a therapeutic perspective, they found that treatment with a specific microbe that promotes the production of compounds in the biopterin family in the gut or treatment with a ...

More importantly from a therapeutic perspective, they found that treatment with a specific microbe that promotes the production of compounds in the biopterin family in the gut or treatment with a ...